title: Toxicity of inhaled chloroprene (2-chloro-1,3-butadiene) in F344 rats and B6C3F(1) mice.
abstract: Chloroprene (2-chloro-1,3-butadiene) is a high production chemical used almost exclusively in the production of polychloroprene (neoprene) elastomer. Because of its structural similarity to isoprene (2-methyl-1,3-butadiene) and to 1,3-butadiene, a potent trans-species carcinogen, inhalation studies were performed on chloroprene to characterize its toxicological potential and to provide a basis for selecting exposure concentrations for chronic toxicity and carcinogenicity studies. Thirteen-week inhalation toxicology studies were conducted in male and female F344 rats and B6C3F(1) mice at exposure concentrations of 0, 5, 12, 32 or 80 ppm (6 h/day; 5 days/week). A 200 ppm exposure group was also included for rats only, because a previous study showed that this concentration of chloroprene is lethal to mice. In mice, exposure to 80 ppm chloroprene caused a marginal decrease in body weight gain in males and epithelial hyperplasia of the forestomach in males and females. This lesion has been observed in mice exposed to isoprene or 1,3-butadiene. In rats, exposure to 80 ppm chloroprene or higher concentrations caused degeneration and metaplasia of the olfactory epithelium and exposure to 200 ppm caused anemia, hepatocellular necrosis and reduced sperm motility. These lesions have not been observed in rats exposed to isoprene or 1,3-butadiene. The profile of toxic effects of chloroprene is considerably different from that of isoprene or 1,3-butadiene; this may be due to differences in exposure concentrations that were used in toxicology studies of these compounds and /or to the influence of the chlorine substitution on the toxicokinetics of these compounds, on their biotransformation, or on the reactivity of metabolic intermediates with tissue macromolecules.
authors.affiliation: National Institute of Environmental Health Services, Research Triangle Park, NC 27709, USA.
authors.forename: R L
authors.initials: RL
authors.lastname: Melnick
authors.forename: M R
authors.initials: MR
authors.lastname: Elwell
authors.forename: J H
authors.initials: JH
authors.lastname: Roycroft
authors.forename: B J
authors.initials: BJ
authors.lastname: Chou
authors.forename: H A
authors.initials: HA
authors.lastname: Ragan
authors.forename: R A
authors.initials: RA
authors.lastname: Miller
mesh_terms: D000280:Administration, Inhalation; D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002737:Chloroprene / Q000008:administration & dosage / Q000633:toxicity*; D004305:Dose-Response Relationship, Drug; D004971:Estrus / Q000187:drug effects; D005260:Female; D007668:Kidney / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D008297:Male; D051379:Mice; D009297:Nasal Mucosa / Q000187:drug effects; D009929:Organ Size / Q000187:drug effects; D009928:Organ Specificity; D051381:Rats; D011916:Rats, Inbred F344; D013081:Sperm Motility / Q000187:drug effects
chemical_list: D002737:Chloroprene